Invasive pulmonary aspergillosis (IPA) is a life-threatening conditions which typically develops in immunosuppressed patients. However admission to intensive care units (ICU) has emerged as a risk factor for the development of IPA, even in those patients without classical risk factors. As the clinical presentation is commonly atypical in non-neutropenic critically ill patients and the isolation of Aspergillus spp. is not always a sign of infection, the diagnosis of this condition often poses a considerable challenge to clinicians. In this retrospective, observational study, all critically ill patients admitted in the ICUs of three hospitals in the Marche region with an Aspergillus spp. isolate obtained from a lower respiratory tract specimen over a six-year period (2019-2024) were classified as infected or colonized according to the main diagnostic criteria, to evaluate differences between colonized and infected patients and factors associated with mortality. A total of 186 patients were identified: in 73 of them IPA was diagnosed with at least one diagnostic algorithm, while 113 were deemed as colonized. Four proven cases were diagnosed by histopathology. Compared to colonized patients, those with IPA more frequently presented with structural lung abnormalities, chronic cardiovascular comorbidity, history of receipt of corticosteroid or other immunosuppressive therapies, severe respiratory viral infection, ARDS, pneumonia, respiratory failure, acute kidney injury, their previous hospitalization was longer, history of receipt antibiotic or antifungal therapy and growth of A. fumigatus; furthermore, galactomannan testing and chest CT were more frequently performed and an antifungal therapy was more frequently prescribed. On the contrary, colonized patients presented higher SOFA score and were more frequently admitted because of hemorrage, stroke or trauma. Thirty-day mortality were higher in the infected group compared to colonized patients (p = 0.11). Factors shown to be independently associated with 30-day mortality were septic shock (OR 4.446, CI 1.022 – 19.339, p 0.047) and infection caused by A. fumigatus (OR 4.486, CI 1.239 – 16.245, p 0.022). Our study confirmed the high mortality of IPA in critically ill patients. Early diagnosis is essential to promptly start an appropriate antifungal treatment, underscoring the potential role of non-culture-based methods and CT-scan in achieving an earlier diagnosis.

Multicenter study of invasive pulmonary aspergillosis in intensive care units: facing the new challenge / Pallotta, Francesco. - (2026 Mar 24).

Multicenter study of invasive pulmonary aspergillosis in intensive care units: facing the new challenge

PALLOTTA, FRANCESCO
2026-03-24

Abstract

Invasive pulmonary aspergillosis (IPA) is a life-threatening conditions which typically develops in immunosuppressed patients. However admission to intensive care units (ICU) has emerged as a risk factor for the development of IPA, even in those patients without classical risk factors. As the clinical presentation is commonly atypical in non-neutropenic critically ill patients and the isolation of Aspergillus spp. is not always a sign of infection, the diagnosis of this condition often poses a considerable challenge to clinicians. In this retrospective, observational study, all critically ill patients admitted in the ICUs of three hospitals in the Marche region with an Aspergillus spp. isolate obtained from a lower respiratory tract specimen over a six-year period (2019-2024) were classified as infected or colonized according to the main diagnostic criteria, to evaluate differences between colonized and infected patients and factors associated with mortality. A total of 186 patients were identified: in 73 of them IPA was diagnosed with at least one diagnostic algorithm, while 113 were deemed as colonized. Four proven cases were diagnosed by histopathology. Compared to colonized patients, those with IPA more frequently presented with structural lung abnormalities, chronic cardiovascular comorbidity, history of receipt of corticosteroid or other immunosuppressive therapies, severe respiratory viral infection, ARDS, pneumonia, respiratory failure, acute kidney injury, their previous hospitalization was longer, history of receipt antibiotic or antifungal therapy and growth of A. fumigatus; furthermore, galactomannan testing and chest CT were more frequently performed and an antifungal therapy was more frequently prescribed. On the contrary, colonized patients presented higher SOFA score and were more frequently admitted because of hemorrage, stroke or trauma. Thirty-day mortality were higher in the infected group compared to colonized patients (p = 0.11). Factors shown to be independently associated with 30-day mortality were septic shock (OR 4.446, CI 1.022 – 19.339, p 0.047) and infection caused by A. fumigatus (OR 4.486, CI 1.239 – 16.245, p 0.022). Our study confirmed the high mortality of IPA in critically ill patients. Early diagnosis is essential to promptly start an appropriate antifungal treatment, underscoring the potential role of non-culture-based methods and CT-scan in achieving an earlier diagnosis.
24-mar-2026
L’aspergillosi polmonare invasiva (IPA) è una condizione potenzialmente letale che tipicamente si sviluppa nei pazienti immunocompromessi. Tuttavia, il ricovero in unità di terapia intensiva (ICU) è emerso come un fattore di rischio per lo sviluppo di IPA anche in pazienti privi dei classici fattori predisponenti. Poiché la presentazione clinica è spesso atipica nei pazienti critici non neutropenici e l’isolamento di Aspergillus spp. non rappresenta sempre un segno di infezione, la diagnosi di questa condizione pone frequentemente notevoli difficoltà ai clinici. In questo studio retrospettivo e osservazionale, tutti i pazienti critici ricoverati nelle ICU di tre ospedali della Regione Marche nei quali era stato isolato Aspergillus spp. da un campione delle basse vie respiratorie nel corso di un periodo di sei anni (2019–2024) sono stati classificati come infetti o colonizzati secondo i principali criteri diagnostici, al fine di valutare le differenze tra pazienti colonizzati e infetti e i fattori associati alla mortalità. È stato identificato un totale di 186 pazienti: in 73 di essi l’IPA è stata diagnosticata tramite almeno un algoritmo diagnostico, mentre 113 sono stati considerati colonizzati. Quattro casi certi sono stati diagnosticati mediante esame istopatologico. Rispetto ai pazienti colonizzati, quelli con IPA presentavano più frequentemente anomalie strutturali del parenchima polmonare, comorbilità cardiovascolari croniche, storia di terapia corticosteroidea o altre terapie immunosoppressive, infezioni virali respiratorie gravi, ARDS, polmonite, insufficienza respiratoria, insufficienza renale acuta; inoltre, risultavano avere una degenza precedente più lunga, aver ricevuto più spesso una terapia antibiotica o antifungina e una maggiore prevalenza di crescita di A. fumigatus. Nei pazienti infetti sono stati più frequentemente eseguiti la valutazione del galattomannano e la TC del torace, e più frequentemente è stata prescritta una terapia antifungina. Al contrario, i pazienti colonizzati presentavano punteggi SOFA più elevati ed più frequentemente sono stati ricoverati per emorragia, ictus o trauma. La mortalità a 30 giorni era più elevata nel gruppo dei pazienti infetti rispetto ai pazienti colonizzati (p = 0.11). I fattori risultati indipendentemente associati alla mortalità a 30 giorni sono risultati essere lo shock settico (OR 4.446, CI 1.022–19.339, p = 0.047) e l’infezione da A. fumigatus (OR 4.486, CI 1.239–16.245, p = 0.022). Il nostro studio conferma l’elevata mortalità dell’IPA nei pazienti critici. La diagnosi precoce è essenziale per iniziare tempestivamente un trattamento antifungino appropriato, evidenziando il potenziale ruolo dei metodi non colturali e della TC toracica nel raggiungimento di una diagnosi più precoce.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/352933
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact